{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:09:27Z","timestamp":1778692167003,"version":"3.51.4"},"reference-count":90,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2020MH104"],"award-info":[{"award-number":["ZR2020MH104"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ec.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,23]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to identify risk factors for osteoporosis (OP) in patients with primary aldosteronism (PA) and to develop a predictive nomogram for estimating OP risk in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We retrospectively enrolled PA patients diagnosed at our hospital between January 2020 and December 2024. The dataset was randomly divided into training (\n                      <jats:italic>n<\/jats:italic>\n                      = 185) and validation (\n                      <jats:italic>n<\/jats:italic>\n                      = 79) sets in a 7:3 ratio. Least absolute shrinkage and selection operator (LASSO) regression combined with multivariate logistic regression was used to identify predictive factors for OP and construct the nomogram. Model discrimination was evaluated using the area under the receiver operating characteristic curve (AUC). Additional performance assessments included the Hosmer\u2013Lemeshow test, calibration curves, and decision curve analysis (DCA).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study included 264 PA patients (mean age 61.2 \u00b1 10.0 years; 110 men, 154 women), with an OP prevalence of 11.4%. LASSO regression identified seven independent predictors: age, sex, body mass index, diabetes history, fasting insulin, plasma aldosterone concentration, and serum creatinine. The nomogram demonstrated strong predictive performance, with AUC values of 0.931 (95% CI: 0.879\u20130.982) in the training set and 0.842 (95% CI: 0.749\u20130.935) in the validation set. Calibration curves and DCA confirmed the model\u2019s clinical utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The developed nomogram effectively predicts OP risk in PA patients, offering valuable clinical utility for early identification of high-risk individuals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/ec-25-0583","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T11:39:16Z","timestamp":1766489956000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":1,"title":["Establishment and validation of a nomogram predicting the risk of osteoporosis with primary aldosteronism"],"prefix":"10.1530","volume":"15","author":[{"given":"Ruidong","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Geriatric Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunqi","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6069-030X","authenticated-orcid":true,"given":"Caixia","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Int J Mol Sci","first-page":"900","article-title":"What we know about and what is new in primary aldosteronism","volume":"25","author":"Ekman N","year":"2024","unstructured":"Ekman N\n, \nGrossman AB\n & \nDworakowska D\n\n. What we know about and what is new in primary aldosteronism. Int J Mol Sci 2024 25 900. (https:\/\/doi.org\/10.3390\/ijms25020900)"},{"key":"bib2","series-title":"Nat Rev Endocrinol","first-page":"665","article-title":"Primary aldosteronism \u2013 a multidimensional syndrome","volume":"18","author":"Turcu AF","year":"2022","unstructured":"Turcu AF\n, \nYang J\n & \nVaidya A\n\n. Primary aldosteronism \u2013 a multidimensional syndrome. Nat Rev Endocrinol 2022 18 665\u2013682. (https:\/\/doi.org\/10.1038\/s41574-022-00730-2)"},{"key":"bib3","series-title":"Eur Soc Endocrinol","first-page":"1","article-title":"Primary aldosteronism as a cause of secondary osteoporosis","volume":"177","author":"Salcuni AS","year":"2017","unstructured":"Salcuni AS\n, \nCarnevale V\n, \nBattista C\n, et al.\n Primary aldosteronism as a cause of secondary osteoporosis. Eur Soc Endocrinol 2017 177 1\u201321. (https:\/\/doi.org\/10.1530\/eje-17-0417)"},{"key":"bib4","series-title":"Endocrinol Metab Clin N Am","first-page":"167","article-title":"Postmenopausal osteoporosis","volume":"50","author":"Arceo-Mendoza RM","year":"2021","unstructured":"Arceo-Mendoza RM\n & \nCamacho PM\n\n. Postmenopausal osteoporosis. Endocrinol Metab Clin N Am 2021 50 167\u2013178. (https:\/\/doi.org\/10.1016\/j.ecl.2021.03.009)"},{"key":"bib5","series-title":"Am J Manag Care","first-page":"e142","article-title":"Economic burden of osteoporotic fractures in US managed care enrollees","volume":"26","author":"Williams SA","year":"2020","unstructured":"Williams SA\n, \nChastek B\n, \nSundquist K\n, et al.\n Economic burden of osteoporotic fractures in US managed care enrollees. Am J Manag Care 2020 26 e142\u2013e149. (https:\/\/doi.org\/10.37765\/ajmc.2020.43156)"},{"key":"bib6","series-title":"Int J Endocrinol","first-page":"1","article-title":"Bone and mineral metabolism in patients with primary aldosteronism","volume":"2014","author":"Petramala L","year":"2014","unstructured":"Petramala L\n, \nZinnamosca L\n, \nSettevendemmie A\n, et al.\n Bone and mineral metabolism in patients with primary aldosteronism. Int J Endocrinol 2014 2014 1\u20136. (https:\/\/doi.org\/10.1155\/2014\/836529)"},{"key":"bib7","series-title":"J Bone Miner Res","first-page":"743","article-title":"Risk of fracture in primary aldosteronism: a population-based cohort study","volume":"32","author":"Wu V-C","year":"2017","unstructured":"Wu V-C\n, \nChang C-H\n, \nWang C-Y\n, et al.\n Risk of fracture in primary aldosteronism: a population-based cohort study. J Bone Miner Res 2017 32 743\u2013752. (https:\/\/doi.org\/10.1002\/jbmr.3033)"},{"key":"bib8","series-title":"Front Endocrinol","article-title":"Bone and mineral metabolism in patients with primary aldosteronism: a systematic review and meta-analysis","volume":"13","author":"Wang A","year":"2022","unstructured":"Wang A\n, \nWang Y\n, \nLiu H\n, et al.\n Bone and mineral metabolism in patients with primary aldosteronism: a systematic review and meta-analysis. Front Endocrinol 2022 13 1027841. (https:\/\/doi.org\/10.3389\/fendo.2022.1027841)"},{"key":"bib9","series-title":"Clin Rev Bone Miner Metabol","first-page":"194","article-title":"Relationship between aldosterone and parathyroid hormone, and the effect of angiotensin and aldosterone inhibition on bone health","volume":"13","author":"Bislev LS","year":"2015","unstructured":"Bislev LS\n, \nSikj\u00e6r T\n, \nRolighed L\n, et al.\n Relationship between aldosterone and parathyroid hormone, and the effect of angiotensin and aldosterone inhibition on bone health. Clin Rev Bone Miner Metabol 2015 13 194\u2013205. (https:\/\/doi.org\/10.1007\/s12018-015-9182-0)"},{"key":"bib10","series-title":"Biochem Biophys Res Commun","first-page":"407","article-title":"Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia","volume":"447","author":"Fumoto T","year":"2014","unstructured":"Fumoto T\n, \nIshii K-A\n, \nIto M\n, et al.\n Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia. Biochem Biophys Res Commun 2014 447 407\u2013412. (https:\/\/doi.org\/10.1016\/j.bbrc.2014.03.149)"},{"key":"bib11","series-title":"Endocr Rev","first-page":"1","article-title":"Secondary osteoporosis","volume":"43","author":"Ebeling PR","year":"2021","unstructured":"Ebeling PR\n, \nNguyen HH\n, \nAleksova J\n, et al.\n Secondary osteoporosis. Endocr Rev 2021 43 1\u201374. (https:\/\/doi.org\/10.1210\/endrev\/bnab028)"},{"key":"bib12","series-title":"Endocrine","first-page":"17","article-title":"Secondary diabetes history due to primary aldosteronism","volume":"79","author":"Moustaki M","year":"2022","unstructured":"Moustaki M\n, \nPaschou SA\n, \nVakali EC\n, et al.\n Secondary diabetes history due to primary aldosteronism. Endocrine 2022 79 17\u201330. (https:\/\/doi.org\/10.1007\/s12020-022-03168-8)"},{"key":"bib13","series-title":"Endocr Pract","first-page":"1","article-title":"American Association of Clinical Endocrinologists\/American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis \u2013 2020 update","volume":"26","author":"Camacho PM","year":"2020","unstructured":"Camacho PM\n, \nPetak SM\n, \nBinkley N\n, et al\n. American Association of Clinical Endocrinologists\/American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis \u2013 2020 update. Endocr Pract 2020 26 (Supp. 1) 1\u201346. (https:\/\/doi.org\/10.4158\/GL-2020-0524SUPPL)"},{"key":"bib14","series-title":"Chin J Bone Joint Surg","first-page":"865","article-title":"China guideline for diagnosis and treatment of senile osteoporosis (2023)","volume":"16","author":"Workgroup of Chinese Guideline for the Diagnosis and Treatment of Senile Osteoporosis","year":"2023","unstructured":"Workgroup of Chinese Guideline for the Diagnosis and Treatment of Senile Osteoporosis\n. China guideline for diagnosis and treatment of senile osteoporosis (2023). Chin J Bone Joint Surg 2023 16 865\u2013885. (https:\/\/doi.org\/10.3969\/j.issn.2095-9958.2023.10.01)"},{"key":"bib15","series-title":"Climacteric","first-page":"1","article-title":"Clinical impact of misinterpretation of dual-energy X-ray absorptiometry during the evaluation of osteoporotic patients","volume":"24","author":"Cerdas P\u00e9rez S","year":"2021","unstructured":"Cerdas P\u00e9rez S\n, \nHerrera LE\n & \nGonz\u00e1lez E\n\n. Clinical impact of misinterpretation of dual-energy X-ray absorptiometry during the evaluation of osteoporotic patients. Climacteric 2021 24 1\u201311. (https:\/\/doi.org\/10.1080\/13697137.2021.1918079)"},{"key":"bib16","series-title":"Curr Rheumatol Rep","first-page":"13","article-title":"Update on imaging-based measurement of bone mineral density and quality","volume":"22","author":"Link TM","year":"2021","unstructured":"Link TM\n & \nKazakia G\n\n. Update on imaging-based measurement of bone mineral density and quality. Curr Rheumatol Rep 2021 22 13. (https:\/\/doi.org\/10.1007\/s11926-020-00892-w)"},{"key":"bib17","series-title":"Arch Osteoporosis","first-page":"9","article-title":"The performance of osteoporosis self-assessment tool for Asians (OSTA) in identifying the risk of osteoporosis among Malaysian population aged 40 years and above","volume":"14","author":"Subramaniam S","year":"2019","unstructured":"Subramaniam S\n, \nChan C-Y\n, \nSoelaiman I-N\n, et al.\n The performance of osteoporosis self-assessment tool for Asians (OSTA) in identifying the risk of osteoporosis among Malaysian population aged 40 years and above. Arch Osteoporosis 2019 14 9. (https:\/\/doi.org\/10.1007\/s11657-019-0666-2)"},{"key":"bib18","series-title":"BJU Int","first-page":"492","article-title":"Can nomograms be superior to other prediction tools?","volume":"103","author":"Shariat SF","year":"2009","unstructured":"Shariat SF\n, \nCapitanio U\n, \nJeldres C\n, et al.\n Can nomograms be superior to other prediction tools? BJU Int 2009 103 492\u2013495 discussion 495-7. (https:\/\/doi.org\/10.1111\/j.1464-410x.2008.08073.x)"},{"key":"bib19","series-title":"Chin J Endocrinol Metab","first-page":"1","article-title":"Expert consensus on the diagnosis and treatment of primary aldosteronism (2024 edition)","volume":"41","author":"Weiqing W","year":"2025","unstructured":"Weiqing W\n\n. Expert consensus on the diagnosis and treatment of primary aldosteronism (2024 edition). Chin J Endocrinol Metab 2025 41 1\u201324. (https:\/\/doi.org\/10.3760\/cma.j.cn311282-20241115-00546)"},{"key":"bib20","series-title":"J Hypertens","first-page":"1919","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the working group on endocrine hypertension of the European Society of Hypertension","volume":"38","author":"Mulatero P","year":"2020","unstructured":"Mulatero P\n, \nMonticone S\n, \nDeinum J\n, et al.\n Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the working group on endocrine hypertension of the European Society of Hypertension. J Hypertens 2020 38 1919\u20131928. (https:\/\/doi.org\/10.1097\/hjh.0000000000002510)"},{"key":"bib21","series-title":"J Bone Miner Res","first-page":"1137","article-title":"The diagnosis of osteoporosis","volume":"9","author":"Kanis JA","year":"1994","unstructured":"Kanis JA\n, \nMelton LJ III\n, \nChristiansen C\n, et al\n. The diagnosis of osteoporosis. J Bone Miner Res 1994 9 1137\u20131141. (https:\/\/doi.org\/10.1002\/jbmr.5650090802)"},{"key":"bib22","series-title":"BMC Med Res Methodol","first-page":"162","article-title":"When and how should multiple imputation be used for handling missing data in randomised clinical trials \u2013 a practical guide with flowcharts","volume":"17","author":"Jakobsen JC","year":"2017","unstructured":"Jakobsen JC\n, \nGluud C\n, \nWetterslev J\n, et al.\n When and how should multiple imputation be used for handling missing data in randomised clinical trials \u2013 a practical guide with flowcharts. BMC Med Res Methodol 2017 17 162. (https:\/\/doi.org\/10.1186\/s12874-017-0442-1)"},{"key":"bib23","series-title":"J Orthop Surg Res","first-page":"609","article-title":"The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis","volume":"16","author":"Salari N","year":"2021","unstructured":"Salari N\n, \nGhasemi H\n, \nMohammadi L\n, et al.\n The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg Res 2021 16 609. (https:\/\/doi.org\/10.1186\/s13018-021-02772-0)"},{"key":"bib24","series-title":"J Bone Miner Res","first-page":"1789","article-title":"The prevalence of osteoporosis in China, a nationwide, multicenter DXA survey","volume":"34","author":"Zeng Q","year":"2019","unstructured":"Zeng Q\n, \nLi N\n, \nWang Q\n, et al.\n The prevalence of osteoporosis in China, a nationwide, multicenter DXA survey. J Bone Miner Res 2019 34 1789\u20131797. (https:\/\/doi.org\/10.1002\/jbmr.3757)"},{"key":"bib25","series-title":"J Bone Miner Res","first-page":"743","article-title":"Risk of fracture in primary aldosteronism: a population\u2010based cohort study","volume":"32","author":"Wu VC","year":"2016","unstructured":"Wu VC\n, \nChang CH\n, \nWang CY\n, et al.\n Risk of fracture in primary aldosteronism: a population\u2010based cohort study. J Bone Miner Res 2016 32 743\u2013752. (https:\/\/doi.org\/10.1002\/jbmr.3033)"},{"key":"bib26","series-title":"Endocr Pract","first-page":"90","article-title":"Association between aldosterone and parathyroid hormone levels in patients with adrenocortical tumors","volume":"6","author":"Zavatta G","year":"2021","unstructured":"Zavatta G\n, \nDi Dalmazi G\n, \nAltieri P\n, et al.\n Association between aldosterone and parathyroid hormone levels in patients with adrenocortical tumors. Endocr Pract 2021 6 90\u201395. (https:\/\/doi.org\/10.1016\/j.eprac.2021.09.002)"},{"key":"bib27","series-title":"J Clin Endocrinol Metab","first-page":"75","article-title":"Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study","volume":"97","author":"Pilz S","year":"2012","unstructured":"Pilz S\n, \nKienreich K\n, \nDrechsler C\n, et al.\n Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study. J Clin Endocrinol Metab 2012 97 75\u201379. (https:\/\/doi.org\/10.1210\/jc.2011-2183)"},{"key":"bib28","series-title":"J Bone Miner Res","first-page":"1261","article-title":"Identification of homogeneous genetic architecture of multiple genetically correlated traits by block clustering of genome-wide associations","volume":"26","author":"Gupta M","year":"2011","unstructured":"Gupta M\n, \nCheung C-L\n, \nHsu Y-H\n, et al.\n Identification of homogeneous genetic architecture of multiple genetically correlated traits by block clustering of genome-wide associations. J Bone Miner Res 2011 26 1261\u20131271. (https:\/\/doi.org\/10.1002\/jbmr.333)"},{"key":"bib29","series-title":"J Orthop Surg Res","first-page":"669","article-title":"Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis","volume":"16","author":"Salari N","year":"2021","unstructured":"Salari N\n, \nDarvishi N\n, \nBartina Y\n, et al.\n Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis. J Orthop Surg Res 2021 16 669. (https:\/\/doi.org\/10.1186\/s13018-021-02821-8)"},{"key":"bib30","series-title":"Front Endocrinol","article-title":"Correlation between plasma aldosterone concentration and bone mineral density in middle-aged and elderly hypertensive patients: potential impact on osteoporosis and future fracture risk","volume":"15","author":"Song S","year":"2024","unstructured":"Song S\n, \nCai X\n, \nHu J\n, et al.\n Correlation between plasma aldosterone concentration and bone mineral density in middle-aged and elderly hypertensive patients: potential impact on osteoporosis and future fracture risk. Front Endocrinol 2024 15 1373862. (https:\/\/doi.org\/10.3389\/fendo.2024.1373862)"},{"key":"bib31","series-title":"Int J Mol Sci","first-page":"5814","article-title":"Hormone-related and drug-induced osteoporosis: a cellular and molecular overview","volume":"24","author":"Wang L-T","year":"2023","unstructured":"Wang L-T\n, \nChen L-R\n & \nChen K-H\n\n. Hormone-related and drug-induced osteoporosis: a cellular and molecular overview. Int J Mol Sci 2023 24 5814. (https:\/\/doi.org\/10.3390\/ijms24065814)"},{"key":"bib32","series-title":"J Hum Hypertens","first-page":"555","article-title":"Postmenopausal osteoporosis is associated with elevated aldosterone\/renin ratio","volume":"32","author":"Xiaoyu Shu MM","year":"2018","unstructured":"Xiaoyu Shu MM\n, \nMa L\n, \nWang Z\n, et al\n. Postmenopausal osteoporosis is associated with elevated aldosterone\/renin ratio. J Hum Hypertens 2018 32 555\u2013563. (https:\/\/doi.org\/10.1038\/s41371-018-0069-7)"},{"key":"bib33","series-title":"Original Basic","first-page":"464","article-title":"Aldosterone perturbs adiponectin and PAI-1 expression and secretion in 3T3-L1 adipocytes","volume":"43","author":"Li P","year":"2011","unstructured":"Li P\n, \nZhang X-N\n, \nPan C-M\n, et al.\n Aldosterone perturbs adiponectin and PAI-1 expression and secretion in 3T3-L1 adipocytes. Original Basic 2011 43 464\u2013469. (https:\/\/doi.org\/10.1055\/s-0031-1277226)"},{"key":"bib34","series-title":"Mol Cell Endocrinol","first-page":"162","article-title":"Genes implicated in insulin resistance are down-regulated in primary aldosteronism patients","volume":"355","author":"Williams TA","year":"2021","unstructured":"Williams TA\n, \nMonticone S\n, \nUrbanet R\n, et al.\n Genes implicated in insulin resistance are down-regulated in primary aldosteronism patients. Mol Cell Endocrinol 2021 355 162\u2013168. (https:\/\/doi.org\/10.1016\/j.mce.2012.02.007)"},{"key":"bib35","series-title":"Sci Rep","article-title":"Establishment and validation of a nomogram clinical prediction model for osteoporosis in senile patients with type 2 diabetes history","volume":"14","author":"Li J","year":"2024","unstructured":"Li J\n, \nZhou X\n, \nWen J\n, et al\n. Establishment and validation of a nomogram clinical prediction model for osteoporosis in senile patients with type 2 diabetes history. Sci Rep 2024 14 5343. (https:\/\/doi.org\/10.1038\/s41598-024-56127-w)"},{"key":"bib36","series-title":"Front Endocrinol","first-page":"122","article-title":"The interplay between bone and glucose metabolism","volume":"11","author":"Cipriani C","year":"2020","unstructured":"Cipriani C\n, \nColangelo L\n, \nSantori R\n, et al.\n The interplay between bone and glucose metabolism. Front Endocrinol 2020 11 122. (https:\/\/doi.org\/10.3389\/fendo.2020.00122)"},{"key":"bib37","series-title":"Bone","article-title":"Advanced glycation and glycoxidation end products in bone","volume":"176","author":"Wang B","year":"2023","unstructured":"Wang B\n & \nVashishth D\n\n. Advanced glycation and glycoxidation end products in bone. Bone 2023 176 116880. (https:\/\/doi.org\/10.1016\/j.bone.2023.116880)"},{"key":"bib38","series-title":"Acta Endocrinol","first-page":"349","article-title":"Insulin resistance and pathogenesis of postmenopausal osteoporosis","volume":"19","author":"Greene D-I-I","year":"2023","unstructured":"Greene D-I-I\n, \nGrigorescu F\n, \nManda D\n, et al.\n Insulin resistance and pathogenesis of postmenopausal osteoporosis. Acta Endocrinol 2023 19 349\u2013363. (https:\/\/doi.org\/10.4183\/aeb.2023.349)"},{"key":"bib39","series-title":"Endocr Res","first-page":"144","article-title":"Possible roles of insulin signaling in osteoblasts","volume":"39","author":"Pramojanee SN","year":"2014","unstructured":"Pramojanee SN\n, \nPhimphilai M\n, \nChattipakorn N\n, et al.\n Possible roles of insulin signaling in osteoblasts. Endocr Res 2014 39 144\u2013151. (https:\/\/doi.org\/10.3109\/07435800.2013.879168)"},{"key":"bib40","series-title":"Biomed Res Int","article-title":"Reduced insulin-like growth factor 1 is associated with insulin resistance in obese prepubertal boys","volume":"2021","author":"Kuang J","year":"2021","unstructured":"Kuang J\n, \nZhang L\n, \nXu Y\n, et al.\n Reduced insulin-like growth factor 1 is associated with insulin resistance in obese prepubertal boys. Biomed Res Int 2021 2021 6680316. (https:\/\/doi.org\/10.1155\/2021\/6680316)"},{"key":"bib41","series-title":"Clin J Am Soc Nephrol","first-page":"348","article-title":"Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C","volume":"3","author":"Baxmann AC","year":"2008","unstructured":"Baxmann AC\n, \nAhmed MS\n, \nMarques N\u2019lia C\n, et al\n. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol 2008 3 348\u2013354. (https:\/\/doi.org\/10.2215\/cjn.02870707)"},{"key":"bib42","series-title":"Front Endocrinol","article-title":"Mechanism and physical activities in bone-skeletal muscle crosstalk","volume":"14","author":"Zhao Z","year":"2024","unstructured":"Zhao Z\n, \nYan K\n, \nGuan Q\n, et al.\n Mechanism and physical activities in bone-skeletal muscle crosstalk. Front Endocrinol 2024 14 1287972. (https:\/\/doi.org\/10.3389\/fendo.2023.1287972)"},{"key":"bib43","series-title":"Clin Chim Acta","first-page":"25","article-title":"Physical activities mediate the correlations between serum creatinine and bone mineral density in Chinese","volume":"524","author":"Guan Y","year":"2021","unstructured":"Guan Y\n, \nLu Y-H\n & \nLei SF\n\n. Physical activities mediate the correlations between serum creatinine and bone mineral density in Chinese. Clin Chim Acta 2021 524 25\u201333. (https:\/\/doi.org\/10.1016\/j.cca.2021.11.025)"},{"key":"bib44","series-title":"BMC Muscoskelet Disord","first-page":"1","article-title":"Correlation between bone density, bone metabolism markers with lipid metabolism markers and body mass index","volume":"25","author":"Han H","year":"2025","unstructured":"Han H\n, \nRan L\n, \nFu D\n, et al\n. Correlation between bone density, bone metabolism markers with lipid metabolism markers and body mass index. BMC Muscoskelet Disord 2025 25 1\u201312. (https:\/\/doi.org\/10.1186\/s12891-024-07284-6)"},{"key":"bib45","series-title":"Front Nutr","article-title":"The saturation effect of body mass index on bone mineral density for people over 50 years old: a cross-sectional study of the US population","volume":"8","author":"Ma M","year":"2021","unstructured":"Ma M\n, \nFeng Z\n, \nLiu X\n, et al.\n The saturation effect of body mass index on bone mineral density for people over 50 years old: a cross-sectional study of the US population. Front Nutr 2021 8 763677. (https:\/\/doi.org\/10.3389\/fnut.2021.763677)"},{"key":"bib1","series-title":"Int J Mol Sci","first-page":"900","article-title":"What we know about and what is new in primary aldosteronism","volume":"25","author":"Ekman N","year":"2024","unstructured":"Ekman N\n, \nGrossman AB\n & \nDworakowska D\n\n. What we know about and what is new in primary aldosteronism. Int J Mol Sci 2024 25 900. (https:\/\/doi.org\/10.3390\/ijms25020900)"},{"key":"bib2","series-title":"Nat Rev Endocrinol","first-page":"665","article-title":"Primary aldosteronism \u2013 a multidimensional syndrome","volume":"18","author":"Turcu AF","year":"2022","unstructured":"Turcu AF\n, \nYang J\n & \nVaidya A\n\n. Primary aldosteronism \u2013 a multidimensional syndrome. Nat Rev Endocrinol 2022 18 665\u2013682. (https:\/\/doi.org\/10.1038\/s41574-022-00730-2)"},{"key":"bib3","series-title":"Eur Soc Endocrinol","first-page":"1","article-title":"Primary aldosteronism as a cause of secondary osteoporosis","volume":"177","author":"Salcuni AS","year":"2017","unstructured":"Salcuni AS\n, \nCarnevale V\n, \nBattista C\n, et al.\n Primary aldosteronism as a cause of secondary osteoporosis. Eur Soc Endocrinol 2017 177 1\u201321. (https:\/\/doi.org\/10.1530\/eje-17-0417)"},{"key":"bib4","series-title":"Endocrinol Metab Clin N Am","first-page":"167","article-title":"Postmenopausal osteoporosis","volume":"50","author":"Arceo-Mendoza RM","year":"2021","unstructured":"Arceo-Mendoza RM\n & \nCamacho PM\n\n. Postmenopausal osteoporosis. Endocrinol Metab Clin N Am 2021 50 167\u2013178. (https:\/\/doi.org\/10.1016\/j.ecl.2021.03.009)"},{"key":"bib5","series-title":"Am J Manag Care","first-page":"e142","article-title":"Economic burden of osteoporotic fractures in US managed care enrollees","volume":"26","author":"Williams SA","year":"2020","unstructured":"Williams SA\n, \nChastek B\n, \nSundquist K\n, et al.\n Economic burden of osteoporotic fractures in US managed care enrollees. Am J Manag Care 2020 26 e142\u2013e149. (https:\/\/doi.org\/10.37765\/ajmc.2020.43156)"},{"key":"bib6","series-title":"Int J Endocrinol","first-page":"1","article-title":"Bone and mineral metabolism in patients with primary aldosteronism","volume":"2014","author":"Petramala L","year":"2014","unstructured":"Petramala L\n, \nZinnamosca L\n, \nSettevendemmie A\n, et al.\n Bone and mineral metabolism in patients with primary aldosteronism. Int J Endocrinol 2014 2014 1\u20136. (https:\/\/doi.org\/10.1155\/2014\/836529)"},{"key":"bib7","series-title":"J Bone Miner Res","first-page":"743","article-title":"Risk of fracture in primary aldosteronism: a population-based cohort study","volume":"32","author":"Wu V-C","year":"2017","unstructured":"Wu V-C\n, \nChang C-H\n, \nWang C-Y\n, et al.\n Risk of fracture in primary aldosteronism: a population-based cohort study. J Bone Miner Res 2017 32 743\u2013752. (https:\/\/doi.org\/10.1002\/jbmr.3033)"},{"key":"bib8","series-title":"Front Endocrinol","article-title":"Bone and mineral metabolism in patients with primary aldosteronism: a systematic review and meta-analysis","volume":"13","author":"Wang A","year":"2022","unstructured":"Wang A\n, \nWang Y\n, \nLiu H\n, et al.\n Bone and mineral metabolism in patients with primary aldosteronism: a systematic review and meta-analysis. Front Endocrinol 2022 13 1027841. (https:\/\/doi.org\/10.3389\/fendo.2022.1027841)"},{"key":"bib9","series-title":"Clin Rev Bone Miner Metabol","first-page":"194","article-title":"Relationship between aldosterone and parathyroid hormone, and the effect of angiotensin and aldosterone inhibition on bone health","volume":"13","author":"Bislev LS","year":"2015","unstructured":"Bislev LS\n, \nSikj\u00e6r T\n, \nRolighed L\n, et al.\n Relationship between aldosterone and parathyroid hormone, and the effect of angiotensin and aldosterone inhibition on bone health. Clin Rev Bone Miner Metabol 2015 13 194\u2013205. (https:\/\/doi.org\/10.1007\/s12018-015-9182-0)"},{"key":"bib10","series-title":"Biochem Biophys Res Commun","first-page":"407","article-title":"Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia","volume":"447","author":"Fumoto T","year":"2014","unstructured":"Fumoto T\n, \nIshii K-A\n, \nIto M\n, et al.\n Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia. Biochem Biophys Res Commun 2014 447 407\u2013412. (https:\/\/doi.org\/10.1016\/j.bbrc.2014.03.149)"},{"key":"bib11","series-title":"Endocr Rev","first-page":"1","article-title":"Secondary osteoporosis","volume":"43","author":"Ebeling PR","year":"2021","unstructured":"Ebeling PR\n, \nNguyen HH\n, \nAleksova J\n, et al.\n Secondary osteoporosis. Endocr Rev 2021 43 1\u201374. (https:\/\/doi.org\/10.1210\/endrev\/bnab028)"},{"key":"bib12","series-title":"Endocrine","first-page":"17","article-title":"Secondary diabetes history due to primary aldosteronism","volume":"79","author":"Moustaki M","year":"2022","unstructured":"Moustaki M\n, \nPaschou SA\n, \nVakali EC\n, et al.\n Secondary diabetes history due to primary aldosteronism. Endocrine 2022 79 17\u201330. (https:\/\/doi.org\/10.1007\/s12020-022-03168-8)"},{"key":"bib13","series-title":"Endocr Pract","first-page":"1","article-title":"American Association of Clinical Endocrinologists\/American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis \u2013 2020 update","volume":"26","author":"Camacho PM","year":"2020","unstructured":"Camacho PM\n, \nPetak SM\n, \nBinkley N\n, et al\n. American Association of Clinical Endocrinologists\/American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis \u2013 2020 update. Endocr Pract 2020 26 (Supp. 1) 1\u201346. (https:\/\/doi.org\/10.4158\/GL-2020-0524SUPPL)"},{"key":"bib14","series-title":"Chin J Bone Joint Surg","first-page":"865","article-title":"China guideline for diagnosis and treatment of senile osteoporosis (2023)","volume":"16","author":"Workgroup of Chinese Guideline for the Diagnosis and Treatment of Senile Osteoporosis","year":"2023","unstructured":"Workgroup of Chinese Guideline for the Diagnosis and Treatment of Senile Osteoporosis\n. China guideline for diagnosis and treatment of senile osteoporosis (2023). Chin J Bone Joint Surg 2023 16 865\u2013885. (https:\/\/doi.org\/10.3969\/j.issn.2095-9958.2023.10.01)"},{"key":"bib15","series-title":"Climacteric","first-page":"1","article-title":"Clinical impact of misinterpretation of dual-energy X-ray absorptiometry during the evaluation of osteoporotic patients","volume":"24","author":"Cerdas P\u00e9rez S","year":"2021","unstructured":"Cerdas P\u00e9rez S\n, \nHerrera LE\n & \nGonz\u00e1lez E\n\n. Clinical impact of misinterpretation of dual-energy X-ray absorptiometry during the evaluation of osteoporotic patients. Climacteric 2021 24 1\u201311. (https:\/\/doi.org\/10.1080\/13697137.2021.1918079)"},{"key":"bib16","series-title":"Curr Rheumatol Rep","first-page":"13","article-title":"Update on imaging-based measurement of bone mineral density and quality","volume":"22","author":"Link TM","year":"2021","unstructured":"Link TM\n & \nKazakia G\n\n. Update on imaging-based measurement of bone mineral density and quality. Curr Rheumatol Rep 2021 22 13. (https:\/\/doi.org\/10.1007\/s11926-020-00892-w)"},{"key":"bib17","series-title":"Arch Osteoporosis","first-page":"9","article-title":"The performance of osteoporosis self-assessment tool for Asians (OSTA) in identifying the risk of osteoporosis among Malaysian population aged 40 years and above","volume":"14","author":"Subramaniam S","year":"2019","unstructured":"Subramaniam S\n, \nChan C-Y\n, \nSoelaiman I-N\n, et al.\n The performance of osteoporosis self-assessment tool for Asians (OSTA) in identifying the risk of osteoporosis among Malaysian population aged 40 years and above. Arch Osteoporosis 2019 14 9. (https:\/\/doi.org\/10.1007\/s11657-019-0666-2)"},{"key":"bib18","series-title":"BJU Int","first-page":"492","article-title":"Can nomograms be superior to other prediction tools?","volume":"103","author":"Shariat SF","year":"2009","unstructured":"Shariat SF\n, \nCapitanio U\n, \nJeldres C\n, et al.\n Can nomograms be superior to other prediction tools? BJU Int 2009 103 492\u2013495 discussion 495-7. (https:\/\/doi.org\/10.1111\/j.1464-410x.2008.08073.x)"},{"key":"bib19","series-title":"Chin J Endocrinol Metab","first-page":"1","article-title":"Expert consensus on the diagnosis and treatment of primary aldosteronism (2024 edition)","volume":"41","author":"Weiqing W","year":"2025","unstructured":"Weiqing W\n\n. Expert consensus on the diagnosis and treatment of primary aldosteronism (2024 edition). Chin J Endocrinol Metab 2025 41 1\u201324. (https:\/\/doi.org\/10.3760\/cma.j.cn311282-20241115-00546)"},{"key":"bib20","series-title":"J Hypertens","first-page":"1919","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the working group on endocrine hypertension of the European Society of Hypertension","volume":"38","author":"Mulatero P","year":"2020","unstructured":"Mulatero P\n, \nMonticone S\n, \nDeinum J\n, et al.\n Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the working group on endocrine hypertension of the European Society of Hypertension. J Hypertens 2020 38 1919\u20131928. (https:\/\/doi.org\/10.1097\/hjh.0000000000002510)"},{"key":"bib21","series-title":"J Bone Miner Res","first-page":"1137","article-title":"The diagnosis of osteoporosis","volume":"9","author":"Kanis JA","year":"1994","unstructured":"Kanis JA\n, \nMelton LJ III\n, \nChristiansen C\n, et al\n. The diagnosis of osteoporosis. J Bone Miner Res 1994 9 1137\u20131141. (https:\/\/doi.org\/10.1002\/jbmr.5650090802)"},{"key":"bib22","series-title":"BMC Med Res Methodol","first-page":"162","article-title":"When and how should multiple imputation be used for handling missing data in randomised clinical trials \u2013 a practical guide with flowcharts","volume":"17","author":"Jakobsen JC","year":"2017","unstructured":"Jakobsen JC\n, \nGluud C\n, \nWetterslev J\n, et al.\n When and how should multiple imputation be used for handling missing data in randomised clinical trials \u2013 a practical guide with flowcharts. BMC Med Res Methodol 2017 17 162. (https:\/\/doi.org\/10.1186\/s12874-017-0442-1)"},{"key":"bib23","series-title":"J Orthop Surg Res","first-page":"609","article-title":"The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis","volume":"16","author":"Salari N","year":"2021","unstructured":"Salari N\n, \nGhasemi H\n, \nMohammadi L\n, et al.\n The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg Res 2021 16 609. (https:\/\/doi.org\/10.1186\/s13018-021-02772-0)"},{"key":"bib24","series-title":"J Bone Miner Res","first-page":"1789","article-title":"The prevalence of osteoporosis in China, a nationwide, multicenter DXA survey","volume":"34","author":"Zeng Q","year":"2019","unstructured":"Zeng Q\n, \nLi N\n, \nWang Q\n, et al.\n The prevalence of osteoporosis in China, a nationwide, multicenter DXA survey. J Bone Miner Res 2019 34 1789\u20131797. (https:\/\/doi.org\/10.1002\/jbmr.3757)"},{"key":"bib25","series-title":"J Bone Miner Res","first-page":"743","article-title":"Risk of fracture in primary aldosteronism: a population\u2010based cohort study","volume":"32","author":"Wu VC","year":"2016","unstructured":"Wu VC\n, \nChang CH\n, \nWang CY\n, et al.\n Risk of fracture in primary aldosteronism: a population\u2010based cohort study. J Bone Miner Res 2016 32 743\u2013752. (https:\/\/doi.org\/10.1002\/jbmr.3033)"},{"key":"bib26","series-title":"Endocr Pract","first-page":"90","article-title":"Association between aldosterone and parathyroid hormone levels in patients with adrenocortical tumors","volume":"6","author":"Zavatta G","year":"2021","unstructured":"Zavatta G\n, \nDi Dalmazi G\n, \nAltieri P\n, et al.\n Association between aldosterone and parathyroid hormone levels in patients with adrenocortical tumors. Endocr Pract 2021 6 90\u201395. (https:\/\/doi.org\/10.1016\/j.eprac.2021.09.002)"},{"key":"bib27","series-title":"J Clin Endocrinol Metab","first-page":"75","article-title":"Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study","volume":"97","author":"Pilz S","year":"2012","unstructured":"Pilz S\n, \nKienreich K\n, \nDrechsler C\n, et al.\n Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study. J Clin Endocrinol Metab 2012 97 75\u201379. (https:\/\/doi.org\/10.1210\/jc.2011-2183)"},{"key":"bib28","series-title":"J Bone Miner Res","first-page":"1261","article-title":"Identification of homogeneous genetic architecture of multiple genetically correlated traits by block clustering of genome-wide associations","volume":"26","author":"Gupta M","year":"2011","unstructured":"Gupta M\n, \nCheung C-L\n, \nHsu Y-H\n, et al.\n Identification of homogeneous genetic architecture of multiple genetically correlated traits by block clustering of genome-wide associations. J Bone Miner Res 2011 26 1261\u20131271. (https:\/\/doi.org\/10.1002\/jbmr.333)"},{"key":"bib29","series-title":"J Orthop Surg Res","first-page":"669","article-title":"Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis","volume":"16","author":"Salari N","year":"2021","unstructured":"Salari N\n, \nDarvishi N\n, \nBartina Y\n, et al.\n Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis. J Orthop Surg Res 2021 16 669. (https:\/\/doi.org\/10.1186\/s13018-021-02821-8)"},{"key":"bib30","series-title":"Front Endocrinol","article-title":"Correlation between plasma aldosterone concentration and bone mineral density in middle-aged and elderly hypertensive patients: potential impact on osteoporosis and future fracture risk","volume":"15","author":"Song S","year":"2024","unstructured":"Song S\n, \nCai X\n, \nHu J\n, et al.\n Correlation between plasma aldosterone concentration and bone mineral density in middle-aged and elderly hypertensive patients: potential impact on osteoporosis and future fracture risk. Front Endocrinol 2024 15 1373862. (https:\/\/doi.org\/10.3389\/fendo.2024.1373862)"},{"key":"bib31","series-title":"Int J Mol Sci","first-page":"5814","article-title":"Hormone-related and drug-induced osteoporosis: a cellular and molecular overview","volume":"24","author":"Wang L-T","year":"2023","unstructured":"Wang L-T\n, \nChen L-R\n & \nChen K-H\n\n. Hormone-related and drug-induced osteoporosis: a cellular and molecular overview. Int J Mol Sci 2023 24 5814. (https:\/\/doi.org\/10.3390\/ijms24065814)"},{"key":"bib32","series-title":"J Hum Hypertens","first-page":"555","article-title":"Postmenopausal osteoporosis is associated with elevated aldosterone\/renin ratio","volume":"32","author":"Xiaoyu Shu MM","year":"2018","unstructured":"Xiaoyu Shu MM\n, \nMa L\n, \nWang Z\n, et al\n. Postmenopausal osteoporosis is associated with elevated aldosterone\/renin ratio. J Hum Hypertens 2018 32 555\u2013563. (https:\/\/doi.org\/10.1038\/s41371-018-0069-7)"},{"key":"bib33","series-title":"Original Basic","first-page":"464","article-title":"Aldosterone perturbs adiponectin and PAI-1 expression and secretion in 3T3-L1 adipocytes","volume":"43","author":"Li P","year":"2011","unstructured":"Li P\n, \nZhang X-N\n, \nPan C-M\n, et al.\n Aldosterone perturbs adiponectin and PAI-1 expression and secretion in 3T3-L1 adipocytes. Original Basic 2011 43 464\u2013469. (https:\/\/doi.org\/10.1055\/s-0031-1277226)"},{"key":"bib34","series-title":"Mol Cell Endocrinol","first-page":"162","article-title":"Genes implicated in insulin resistance are down-regulated in primary aldosteronism patients","volume":"355","author":"Williams TA","year":"2021","unstructured":"Williams TA\n, \nMonticone S\n, \nUrbanet R\n, et al.\n Genes implicated in insulin resistance are down-regulated in primary aldosteronism patients. Mol Cell Endocrinol 2021 355 162\u2013168. (https:\/\/doi.org\/10.1016\/j.mce.2012.02.007)"},{"key":"bib35","series-title":"Sci Rep","article-title":"Establishment and validation of a nomogram clinical prediction model for osteoporosis in senile patients with type 2 diabetes history","volume":"14","author":"Li J","year":"2024","unstructured":"Li J\n, \nZhou X\n, \nWen J\n, et al\n. Establishment and validation of a nomogram clinical prediction model for osteoporosis in senile patients with type 2 diabetes history. Sci Rep 2024 14 5343. (https:\/\/doi.org\/10.1038\/s41598-024-56127-w)"},{"key":"bib36","series-title":"Front Endocrinol","first-page":"122","article-title":"The interplay between bone and glucose metabolism","volume":"11","author":"Cipriani C","year":"2020","unstructured":"Cipriani C\n, \nColangelo L\n, \nSantori R\n, et al.\n The interplay between bone and glucose metabolism. Front Endocrinol 2020 11 122. (https:\/\/doi.org\/10.3389\/fendo.2020.00122)"},{"key":"bib37","series-title":"Bone","article-title":"Advanced glycation and glycoxidation end products in bone","volume":"176","author":"Wang B","year":"2023","unstructured":"Wang B\n & \nVashishth D\n\n. Advanced glycation and glycoxidation end products in bone. Bone 2023 176 116880. (https:\/\/doi.org\/10.1016\/j.bone.2023.116880)"},{"key":"bib38","series-title":"Acta Endocrinol","first-page":"349","article-title":"Insulin resistance and pathogenesis of postmenopausal osteoporosis","volume":"19","author":"Greene D-I-I","year":"2023","unstructured":"Greene D-I-I\n, \nGrigorescu F\n, \nManda D\n, et al.\n Insulin resistance and pathogenesis of postmenopausal osteoporosis. Acta Endocrinol 2023 19 349\u2013363. (https:\/\/doi.org\/10.4183\/aeb.2023.349)"},{"key":"bib39","series-title":"Endocr Res","first-page":"144","article-title":"Possible roles of insulin signaling in osteoblasts","volume":"39","author":"Pramojanee SN","year":"2014","unstructured":"Pramojanee SN\n, \nPhimphilai M\n, \nChattipakorn N\n, et al.\n Possible roles of insulin signaling in osteoblasts. Endocr Res 2014 39 144\u2013151. (https:\/\/doi.org\/10.3109\/07435800.2013.879168)"},{"key":"bib40","series-title":"Biomed Res Int","article-title":"Reduced insulin-like growth factor 1 is associated with insulin resistance in obese prepubertal boys","volume":"2021","author":"Kuang J","year":"2021","unstructured":"Kuang J\n, \nZhang L\n, \nXu Y\n, et al.\n Reduced insulin-like growth factor 1 is associated with insulin resistance in obese prepubertal boys. Biomed Res Int 2021 2021 6680316. (https:\/\/doi.org\/10.1155\/2021\/6680316)"},{"key":"bib41","series-title":"Clin J Am Soc Nephrol","first-page":"348","article-title":"Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C","volume":"3","author":"Baxmann AC","year":"2008","unstructured":"Baxmann AC\n, \nAhmed MS\n, \nMarques N\u2019lia C\n, et al\n. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol 2008 3 348\u2013354. (https:\/\/doi.org\/10.2215\/cjn.02870707)"},{"key":"bib42","series-title":"Front Endocrinol","article-title":"Mechanism and physical activities in bone-skeletal muscle crosstalk","volume":"14","author":"Zhao Z","year":"2024","unstructured":"Zhao Z\n, \nYan K\n, \nGuan Q\n, et al.\n Mechanism and physical activities in bone-skeletal muscle crosstalk. Front Endocrinol 2024 14 1287972. (https:\/\/doi.org\/10.3389\/fendo.2023.1287972)"},{"key":"bib43","series-title":"Clin Chim Acta","first-page":"25","article-title":"Physical activities mediate the correlations between serum creatinine and bone mineral density in Chinese","volume":"524","author":"Guan Y","year":"2021","unstructured":"Guan Y\n, \nLu Y-H\n & \nLei SF\n\n. Physical activities mediate the correlations between serum creatinine and bone mineral density in Chinese. Clin Chim Acta 2021 524 25\u201333. (https:\/\/doi.org\/10.1016\/j.cca.2021.11.025)"},{"key":"bib44","series-title":"BMC Muscoskelet Disord","first-page":"1","article-title":"Correlation between bone density, bone metabolism markers with lipid metabolism markers and body mass index","volume":"25","author":"Han H","year":"2025","unstructured":"Han H\n, \nRan L\n, \nFu D\n, et al\n. Correlation between bone density, bone metabolism markers with lipid metabolism markers and body mass index. BMC Muscoskelet Disord 2025 25 1\u201312. (https:\/\/doi.org\/10.1186\/s12891-024-07284-6)"},{"key":"bib45","series-title":"Front Nutr","article-title":"The saturation effect of body mass index on bone mineral density for people over 50 years old: a cross-sectional study of the US population","volume":"8","author":"Ma M","year":"2021","unstructured":"Ma M\n, \nFeng Z\n, \nLiu X\n, et al.\n The saturation effect of body mass index on bone mineral density for people over 50 years old: a cross-sectional study of the US population. Front Nutr 2021 8 763677. (https:\/\/doi.org\/10.3389\/fnut.2021.763677)"}],"container-title":["Endocrine Connections"],"original-title":[],"link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/15\/1\/EC-25-0583.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/15\/1\/EC-25-0583.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/15\/1\/EC-25-0583.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:55:51Z","timestamp":1769766951000},"score":1,"resource":{"primary":{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/15\/1\/EC-25-0583.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":90,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1530\/ec-25-0583","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]}}}